Summary
The product HGH 10 IU, manufactured by Endura Biosciences CO., LTD, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 002, was submitted by Endura Biosciences and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the amount of recombinant Human Growth Hormone (rHGH) in the vial at 4.05 mg, equivalent to 12.15 IU, 21.5% above the labeled claim of 10 IU. The product’s purity was determined to be 96.029%, with no detected dimer or related proteins.
The testing process began on 6 September 2024, with the sample received on 13 September 2024, and analysis completed on 18 September 2024. While the results confirm high purity and slightly elevated dosing, scrutiny of reseller-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Endura Biosciences CO., LTD
- Product Name: HGH 10 IU
- Active Ingredient: Recombinant Human Growth Hormone (rHGH)
- Batch Number: 002
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #48894
- Testing Ordered: 6 September 2024
- Sample Received: 13 September 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Endura Biosciences
- Analysis Paid For By: Endura Biosciences
Testing Results
- Specification: 10 IU (as stated on the label)
- Measured Concentration: 12.15 IU (4.05 mg)
- Accuracy: 121.5% (21.5% above the label claim)
- Purity: 96.029%
- Dimer and Related Proteins: None detected
Verification Details
- Verification URL: https://janoshik.com/tests/48894_NW27J2X8CCP6
Evaluation of Reseller-Submitted Testing
This analysis highlights the high purity and accurate dosing of the tested product but also raises concerns due to slight overdosing. Since Endura Biosciences submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that HGH 10 IU is slightly overdosed, with a measured concentration of 12.15 IU (4.05 mg), and maintains a high purity of 96.029%, with no detected dimer or related proteins. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding peptide and growth hormone products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
